Journal article

Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital

Diletta Bianchini, David Lorente, Pasquale Rescigno, Zafeiris Zafeiriou, Elena Psychopaida, Hazel O'Sullivan, Mervyn Alaras, Michael Kolinsky, Semini Sumanasuriya, Mariane Sousa Fontes, Joaquin Mateo, Raquel Perez Lopez, Nina Tunariu, Nikolaos Fotiadis, Pardeep Kumar, Alison Tree, Nicholas Van As, Vincent Khoo, Chris Parker, Rosalind Eeles Show all

Clinical Genitourinary Cancer | CIG MEDIA GROUP, LP | Published : 2017

University of Melbourne Researchers

Grants

Awarded by Department of Defense (DoD grant)


Awarded by Royal Marsden


Awarded by Department of Health


Awarded by Prostate Cancer Foundation/SU2C


Awarded by PCF Young Investigator Award


Awarded by Prostate Cancer UK-Medical Research Council Fellowship


Awarded by Cancer Research UK


Awarded by Medical Research Council


Awarded by National Institute for Health Research


Funding Acknowledgements

We acknowledge support from the Department of Defense (DoD grant number UWSC7395), Prostate Cancer UK and Movember to the London Movember Prostate Cancer Centre of Excellence at The Institute of Cancer Research and Royal Marsden (grant number CEO013-2-002), the Prostate Cancer Foundation and through an Experimental Cancer Medical Centre (ECMC) grant from Cancer Research UK and the Department of Health (Ref: C51/A7401). The authors acknowledge NHS funding to the NIHR Biomedical Research Centre at the Royal Marsden and The Institute of Cancer Research. This research was partially funded by grants from the Prostate Cancer Foundation/SU2C to the International Prostate Cancer Dream team (SU2C-AACR-DT0712, PCF grants 20131017 & 20131017-1) as well as Cancer Research UK (Centre Programme grant), Experimental Cancer Medicine Centre grant funding from Cancer Research UK and the Department of Health to the Royal Marsden. J. Mateo was supported by a PCF Young Investigator Award (Grant ref. 16 YOUN11) and by Prostate Cancer UK-Medical Research Council Fellowship (Grant ref. MR/M003272/1).